These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 29938577

  • 1. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A, Ortombina A, Boschi F, Cremonini E, Boaretti M, Sorio C, Melotti P, Bergamini G, Lleo M.
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [Abstract] [Full Text] [Related]

  • 2. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
    Sandri A, Lleo MM, Signoretto C, Boaretti M, Boschi F.
    Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
    [Abstract] [Full Text] [Related]

  • 3. In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin.
    Stellari F, Bergamini G, Sandri A, Donofrio G, Sorio C, Ruscitti F, Villetti G, Assael BM, Melotti P, Lleo MM.
    J Transl Med; 2015 Aug 04; 13():251. PubMed ID: 26239109
    [Abstract] [Full Text] [Related]

  • 4. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y, Huang J, Li L, Liu L.
    Cell Physiol Biochem; 2017 Aug 04; 42(4):1657-1669. PubMed ID: 28738346
    [Abstract] [Full Text] [Related]

  • 5. Scnn1b-Transgenic BALB/c Mice as a Model of Pseudomonas aeruginosa Infections of the Cystic Fibrosis Lung.
    Brao KJ, Wille BP, Lieberman J, Ernst RK, Shirtliff ME, Harro JM.
    Infect Immun; 2020 Aug 19; 88(9):. PubMed ID: 32631918
    [Abstract] [Full Text] [Related]

  • 6. Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.
    Yu H, Hanes M, Chrisp CE, Boucher JC, Deretic V.
    Infect Immun; 1998 Jan 19; 66(1):280-8. PubMed ID: 9423869
    [Abstract] [Full Text] [Related]

  • 7. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.
    Willcox MDP, Zhu H, Conibear TCR, Hume EBH, Givskov M, Kjelleberg S, Rice SA.
    Microbiology (Reading); 2008 Aug 19; 154(Pt 8):2184-2194. PubMed ID: 18667552
    [Abstract] [Full Text] [Related]

  • 8. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
    Vermilyea DM, Crocker AW, Gifford AH, Hogan DA.
    J Bacteriol; 2021 Jun 08; 203(13):e0010021. PubMed ID: 33927050
    [Abstract] [Full Text] [Related]

  • 9. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E, Sass A, Lemarcq A, Dandekar AA, Coenye T, Crabbé A.
    Sci Rep; 2019 Sep 06; 9(1):12859. PubMed ID: 31492943
    [Abstract] [Full Text] [Related]

  • 10. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.
    Marteyn BS, Burgel PR, Meijer L, Witko-Sarsat V.
    Front Cell Infect Microbiol; 2017 Sep 06; 7():243. PubMed ID: 28713772
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ, Jayne JG, Sun M, Kimura E, Meinert J, Wang JC, Schaal JB, Tran D, Rao AP, Akbari O, Selsted ME, Beringer PM.
    Antimicrob Agents Chemother; 2017 Aug 06; 61(8):. PubMed ID: 28559270
    [Abstract] [Full Text] [Related]

  • 12. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J, Dong B, Wang K, Cai S, Liu T, Cheng X, Lei D, Chen Y, Li Y, Kong J, Chen Y.
    PLoS One; 2017 Aug 06; 12(4):e0176883. PubMed ID: 28453568
    [Abstract] [Full Text] [Related]

  • 13. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B.
    Am J Respir Crit Care Med; 2009 Jul 15; 180(2):138-45. PubMed ID: 19423715
    [Abstract] [Full Text] [Related]

  • 14. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK, Radzioch D, Stevenson MM.
    Pediatr Pulmonol; 2000 Nov 15; 30(5):413-24. PubMed ID: 11064433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
    Song Z, Wu H, Ciofu O, Kong KF, Høiby N, Rygaard J, Kharazmi A, Mathee K.
    J Med Microbiol; 2003 Sep 15; 52(Pt 9):731-740. PubMed ID: 12909647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Høiby N.
    Antimicrob Agents Chemother; 2007 Oct 15; 51(10):3677-87. PubMed ID: 17620382
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.